openPR Logo
Press release

Preimplantation Genetic Testing Market is Projected to Grow at Nearly 9% CAGR

11-10-2022 11:39 AM CET | Health & Medicine

Press release from: Fact.MR

/ PR Agency: Fact.MR
As per a survey conducted by Fact.MR, the global preimplantation genetic testing market reached a valuation of US$ 550 million in 2020, expanding at a CAGR of 8% between 2016 and 2020.

Owing to the increase in incidence of chronic diseases and disabilities across the globe, the market for preimplantation genetic testing is estimated to surge at a robust CAGR of 9% over the forecast period 2022 to 2032.

For More Information On How To Improve Your Preimplantation Genetic Testing Market Footprint, Request A Sample Here

https://www.factmr.com/connectus/sample?flag=S&rep_id=292

Preimplantation genetic testing is gaining traction on the back of rising prevalence of genetic disorders among children and disabilities among the aged population. According to a study by Genetic Alliance, in the U.K., out of every 25 children, 1 child is affected by a genetic disorder and nearly 30,000 babies are diagnosed with the disease every year. Besides this, over 500 million adults and children are living with a genetic disorder in the country.

As preimplantation genetic testing is proven as an effective solution for diagnostics of genetic disorders, it is increasingly being used by healthcare providers and institutions for identifying defects present in embryos before implantation.

Thus, the need for effective diagnostic solutions to curb the rising prevalence of genetic disorders in newborns will spur the demand for preimplantation genetic testing over the coming years.

Embryo Human leukocyte antigen (HLA) typing for stem cell therapy is anticipated to dominate the market, accounting for over 40% of the revenue share. In response to the increasing application of preimplantation genetic testing in the procedure, the segment is projected to surpass a valuation of US$ 70 million by the end of 2031.

Key Takeaways from Preimplantation Genetic Testing Market Survey

• The U.S. preimplantation genetic testing market is anticipated to project rapid growth, owing to the increasing prevalence of genetic disorders such as Down syndrome among babies.
• In Europe, the U.K. is estimated to remain a dominant market in the region, expanding at a CAGR of 8% during the forecast period.
• Favored by the increasing investment in the healthcare industry, the market in China and India, collectively is likely to contribute around 60% of the total revenue share through 2031.
• Based on the test type, genetic screening is expected to emerge as the most preferred type of preimplantation genetic testing, accounting for nearly 2/3rd of the market revenue share by 2031.
• Next-generation sequencing (NGS) is dominating the technology segment and is estimated to exceed a revenue of US$ 200 million during the assessment period.

Key Drivers

• Rising prevalence of genetic disorders among babies is fueling the demand for preimplantation genetic testing.
• Increasing use of preimplantation genetic testing for diagnosing minor disabilities and fatal diseases such as cancer is driving the market.
• Growing awareness amongst healthcare professionals regarding the effectiveness of genetic testing methods will spur the market growth.

Connect to an Expert:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=292

Key Restraints

• High cost of preimplantation genetic testing is a factor hampering the market growth.
• Lack of skilled professionals for preimplantation genetic testing is restraining the growth of the market.
• The outbreak has negatively impacted the market due to the restrictions on genetic clinics amid lockdown.

Competitive Landscape

The global market for preimplantation genetic testing is highly consolidated, where a small group of leading players are accounting for nearly half of the global sales. Key player in the landscape are focusing on engaging into strategic collaboration with other players to strengthen their market footprint. For instance,

• In May 2021, United Airlines and Abbott Laboratories announced entering into a collaboration to utilize Abbott's NAVICA app and Abbott's BinaxNOW™ COVID-19 Home Test to enhance the international travel experience.
• In March 2018, Thermo Fisher Scientific, one of the life science leaders, acquired Qiagen, a diagnostics company in $11.5 billion. The acquisition will assist the company in enhancing R&D expertise and industry-leading capabilities to accelerate innovation and cater to emerging healthcare needs.

Some of the prominent preimplantation genetic testing providers profiled by Fact.MR are:

• Agilent Technologies Inc.
• Abbott Laboratories
• CooperSurgical Inc.
• Oxford Gene Technology IP
• Illumina Inc.
• Thermo Fisher Scientific Inc.
• PerkinElmer Inc.
• Genea Limited
• Natera Inc.
• Rubicon Genomics Inc.
• CombiMatrix Corporation

Choose Quick and Secure PayPal Payment Mode to Get Full Access of This Report-

https://www.factmr.com/checkout/292

Preimplantation genetic testing market with detailed segmentation:

• Test Type
o Preimplantation Genetic Diagnostics
o Preimplantation Genetic Screening

• End User
o Preimplantation Genetic Testing in Hospitals
o Preimplantation Genetic Testing in Diagnostic Labs
o Preimplantation Genetic Testing in Research & Academic Institutions
o Preimplantation Genetic Testing in Specialized Clinics
o Preimplantation Genetic Testing by Other End Users

• Application
o Preimplantation Genetic Testing for Embryo HLA Typing for Stem Cell Therapy
o Preimplantation Genetic Testing for IVF Prognosis
o Preimplantation Genetic Testing for Late-Onset Genetic Disorders
o Preimplantation Genetic Testing for Inherited Genetic Diseases
o Preimplantation Genetic Testing for Other Applications

• Technology
o NGS-based Preimplantation Genetic Testing
o PCR-based Preimplantation Genetic Testing
o FISH-based Preimplantation Genetic Testing
o CGH-based Preimplantation Genetic Testing
o SNP-based Preimplantation Genetic Testing

Bleeding Disorders Treatment Market: https://www.newswire.co.kr/newsRead.php?no=948105

Omics Based Clinical Trials Market: https://www.newswire.co.kr/newsRead.php?no=946605

21st floor , 136 Sejong-daero,
Seoul,100-768
South Korea

Market research and consulting agency with a difference! That's why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range - from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we'll be an able research partner.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Preimplantation Genetic Testing Market is Projected to Grow at Nearly 9% CAGR here

News-ID: 2801543 • Views:

More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand for
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Advances in 2D, Cart-Based Systems & AI-Enabled Portability
10-08-2025 | Health & Medicine
Fact.MR
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva …
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems. Key
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethicon US LLC, Cardica Inc., Smith & Nephew Plc, CONMED Corporation., Purple Surgical Inc., Dextera Surgical Inc, and Others.
10-08-2025 | Health & Medicine
Fact.MR
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico …
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rate

All 5 Releases


More Releases for Gene

DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034" The DNA and Gene Cloning Services Market Size is valued
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period? The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks. The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies. In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal